Kjell Andersson, based in Gothenburg, SE, is currently a Chief Scientific Officer at Cinclus Pharma Holding AB, bringing experience from previous roles at Cinclus Pharma AG and AstraZeneca. Kjell Andersson holds a 1990 - 1996 Ph.D. in Pharmacology @ Lund University. Kjell Andersson has 1 email on RocketReach.